Phaedra Chrousos

All filings by Phaedra Chrousos on record concern Vanda Pharmaceuticals Inc., in the capacity of senior executive. Over a trading history stretching from 10 June 2021 to 4 June 2026, the count stands at 7 filings.

On the market, this insider has only sold: 1 sale, €33k in total. Outside the open market, there are 6 share grants.

On 8 June 2026 came the latest disclosure, a share grant in Vanda Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.